News | May 13, 2024
Briefs: Lupin and Aurobindo Pharma
Lupin updates on shipment of Mirabegron ER Tablets
Lupin updates on shipment of Mirabegron ER Tablets
The company is committed to address this observation comprehensively within stipulated time
Ashland's nutraceuticals business supplies a broad portfolio of active ingredients and formulation aids to nutritional product companies
Wacker Biotech US, a wholly owned subsidiary of Wacker Chemie AG, specializes in the microbial production of pDNA
Cellectis is also eligible to receive an investigational new drug (IND) option fee and development
The Unit currently caters to emerging markets of Latin America and Africa with a variety of dosage forms
Eugia Pharma Specialities receives 7 observations from USFDA for Unit II
The project funding will be done through a mix of internal accruals and debts.
2024 full-year revenue guidance raised by US$ 2 billion
New advanced technology-enabled offering aims to streamline synthetic route identification for novel active pharmaceutical ingredients (APIs)
Subscribe To Our Newsletter & Stay Updated
